Cooper Companies Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Good morning for those of you on the West Coast and good afternoon for those on the East Coast. This is Marissa Bych with Morgan Stanley medtech equity research. And I'm back again with now, Brian Andrews, the CFO and Treasurer of Cooper Companies; and Kim Duncan, the VP of Investor Relations. Brian and Kim, it's great to have you with us. I think this is the first time we've had you for a live presentation at our Morgan Stanley healthcare conference. So hopefully, the first of many and hopefully in person next year. We'll see. But great to have you here.
Questions & Answers
There are a number of dynamics, I think, we should talk about today. We can talk about kind of near-term COVID-19 recovery and then some of the new product launches. MiSight, most importantly, has been a focus. And maybe get into some of the financials as well.
But let's just start with the nearer term, if that's
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |